serine/threonine Kinase 17a (STK17A) Peptide
STK17A
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN984559
Aperçu rapide pour serine/threonine Kinase 17a (STK17A) Peptide (ABIN984559)
Antigène
STK17A
(serine/threonine Kinase 17a (STK17A))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-STK17A antibody (Catalog #: AVARP02028_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- STK17A (serine/threonine Kinase 17a (STK17A))
-
Sujet
-
STK17A belongs to the protein kinase superfamily, CAMK Ser/Thr protein kinase family, DAP kinase subfamily. It contains 1 protein kinase domain. STK17A acts as a positive regulator of apoptosis.This gene is a member of the DAP kinase-related apoptosis-inducing protein kinase family and encodes an autophosphorylated nuclear protein with a protein kinase domain. The protein has apoptosis-inducing activity.
Alias Symbols: DRAK1
Protein Interaction Partner: STK17A,STK17A
Protein Size: 414 -
Poids moléculaire
- 46 kDa
-
ID gène
- 9263
-
NCBI Accession
- NM_004760, NP_004751
-
UniProt
- Q9UEE5
Antigène
-
Vous êtes ici:
